Risk of malignant lymphoma following viral hepatitis infection

International Journal of Hematology

Volumn 87, Issue 5, 2008, Pages 474-483

  Cocco, Pierluigi ^a   Piras, Giovanna ^b   Monne, Maria ^b   Uras, Antonella ^b   Gabbas, Attilio ^b   Ennas, Maria G ^a   Palmas, Angelo ^b   Murineddu, Marco ^b   Collu, Stefania ^a   Melis, Massimo ^a   Rais, Marco ^c   Todde, Pierfelice ^d   Cabras, Maria G ^c   Angelucci, Emanuele ^c   Massarelli, Giovannino ^e   Nieters, Alexandra ^f  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b SAN FRANCESCO HOSPITAL   (Italy)

^c Ospedale Oncologico A Businco   (Italy)

^d BROTZU HOSPITAL   (Italy)

^e UNIVERSITY OF SASSARI   (Italy)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Epidemiology; Hepatitis B; Hepatitis C; Lymphoma

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HUMAN; INCIDENCE; ITALY; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PREVALENCE; RISK FACTOR; VIRUS HEPATITIS; WORLD HEALTH ORGANIZATION;

ADULT; AGED; FEMALE; HEPATITIS B; HEPATITIS C, CHRONIC; HUMANS; ITALY; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 46149112992     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-008-0086-3     Document Type: Article

References (42)

1. Luppi M, Torelli G. The new lymphotropic herpes viruses (HHV-6, HHV-7, HHV-8) and hepatitis C virus (HCV) in human lymphoproliferative diseases: an overview. Haematologica. 1996;81:265-81.
2. Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci. 2004;95:745-52.
3. Talamini R, Montella M, Crovatto M, et al. Non-Hodgkin's lymphoma and hepatitis C virus: a case-control from northern and southern Italy. Int J Cancer. 2004;110:380-5.
4. Mele A, Pulsoni A, Elvira Bianco E, et al. Hepatitis C virus and B cell non-Hodgkin lymphomas: an Italian multi-centre case-control study. Blood. 2003;102:996-9.
5. Seve P, Renaudier P, Sasco AJ, et al. Hepatitis C virus infection and B cell non-Hodgkin's lymphoma: a cross-sectional study in Lyon, France. Eur J Gastroenterol Hepatol. 2004;16:1361-5.
6. Cowgill KD, Loffredo CA, Eissa SA, et al. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int J Epidemiol. 2004;33:1034-9.
7. Takeshita M, Sakai H, Okamura S, et al. Prevalence of hepatitis C virus infection in cases of B cell lymphoma in Japan. Histopathology. 2006;48:189-98.
8. Morton LM, Engels EA, Holford TR, et al. Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women. Cancer Epidemiol Biomarkers Prev. 2004;13:425-30.
9. De Sanjose S, Nieters A, Goedert JJ, et al. Role of Hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer. 2004;111:81-5.
10. Duberg AS, Nordstrom M, Torner A, et al. Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology. 2005;41:652-9.
11. Crook PD, Jones ME, Hall AJ. Mortality of hepatitis B surface antigen-positive blood donors in England and Wales. Int J Epidemiol. 2003;32:118-24.
12. Nieters A, Kallinowski B, Brennan P, et al. Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology. 2006;131:1879-86.
13. Isikdogan A, Ayyildiz O, Dursun M, Tiftik N, Batun S, Muftuoglu E. Hepatitis C virus in patients with non-Hodgkin's lymphoma in southeastern Anatolia region of Turkey: a prospective case-control study of 119 patients. Leuk Lymphoma. 2003;44:1745-7.
14. Salem Z, Nuwaiyri-Salti N, Ramlawi F, Ramia S. Hepatitis C virus infection in Lebanese patients with B cell non-Hodgkin's lymphoma. Eur J Epidemiol. 2003;18:251-3.
15. Aviles A, Valdez L, Halabe J, et al. No association between lymphoma and hepatitis C virus. Med Oncol. 2003;20:165-8.
16. Engels EA, Chatterjee N, Cerhan JR, et al. Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer. 2004;111:76-80.
17. Franceschi S, Polesel J, Rickenbach M, et al. Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV cohort Study. Br J Cancer. 2006;95:1598-602.
18. Negri E, Little D, Boiocchi M, et al. B cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer. 2004;111:1-8.
19. Turner NC, Dusheiko G, Jones A. Hepatitis C and B cell lymphoma. Ann Oncol. 2003;14:1341-5.
20. Waters L, Stebbing J, Mandalia S, et al. Hepatitis C infection is not associated with systemic HIV-associated non-Hodgkin's lymphoma: a cohort study. Int J Cancer. 2005;116:161-3.
21. Mazzaro C, Tirelli U, Pozzato G. Hepatitis C virus and non-Hodgkin's lymphoma 10 years later. Dig Liver Dis. 2005;37:219-26.
22. Vallisa D, Bernuzzi P, Arcaini L, et al. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B cell, non-Hodgkin's lymphoma: a multicenter Italian experience. J Clin Oncol. 2005;23:468-73.
23. Armor JF, Fazili J, Toubia N, Kern W, Kamble R, Kharfan-Dabaja MA. Remission of natural-killer cell lymphoma of the liver with anti-hepatitis C therapy. Am J Hematol. 2005;78:212-5.
24. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno-Otero R. Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther. 2005;21:653-62.
25. Mazzaro C, Spina M, Tirelli U. Regression of low-grade non-Hodgkin's lymphoma after treatment with pegylated interferon plus ribavirin in hepatitis C virus infection. J Clin Oncol. 2005;23:4470-1.
26. Kelaidi C, Rollot F, Park S, et al. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas. Leukemia. 2004;18:1711-6.
27. Svoboda J, Andreadis C, Downs LH, Miller WT Jr, Tsai DE, Schuster SJ. Regression of advanced non-splenic marginal zone lymphoma after treatment of hepatitis C virus infection. Leuk Lymphoma. 2005;46:1365-8.
28. Wu H, Zhu K, Levin LI, et al. Self-reported hepatitis and non-Hodgkin lymphoma: an analysis according to the time since hepatitis diagnosis. Ann Epidemiol. 2006;16:400-5.
29. Marcucci F, Mele A, Spada E, et al. High prevalence of hepatitis B virus infection in B cell non-Hodgkin's lymphoma. Haematologica. 2006;91:554-7.
30. Ulcickas Yood M, Quesenberry CP Jr, Guo D, et al. Incidence of non-Hodgkin's lymphoma among individuals with chronic hepatitis B virus infection. Hepatology. 2007;46:107-12.
31. Kuniyoshi M, Nakamuta M, Sakai H, et al. Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol. 2001;16:215-9.
32. Wang F, Xu RH, Han B, et al. High incidence of hepatitis B virus infection in B cell subtype non-Hodgkin lymphoma compared with other cancers. Cancer. 2007;109:1360-4.
33. Loviselli A, Oppo A, Velluzzi F, et al. Independent expression of serological markers of thyroid autoimmunity and hepatitis C infection in the general population: results of a community-based study in north-western Sardinia. J Endocrinol Invest. 1999;22:660-5.
34. Mele A, Mariano A, Tosti ME, et al. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. Clin Infect Dis. 2007;44:e17-24.
35. Vulcano A, Angelucci M, Candelori E, et al. HEV prevalence in the general population and among workers at zoonotic risk in Latium Region. Ann Ig. 2007;19:181-6.
36. Gessoni G, Manoni F. Hepatitis E virus infection in north-east Italy: serological study in the open population and groups at risk. Viral Hepat. 1996;3:197-202.
37. Besson H, Brennan P, Becker N, et al. Tobacco smoking, alcohol drinking and Hodgkin's lymphoma: an European multi-centre case-control study (Epilymph). Br J Cancer. 2006;95:378-84.
38. Silvestri F, Barillari G, Fanin R, et al. Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma. Ann Oncol. 1998;9:499-504.
39. Arcaini L, Paulli M, Boveri E, et al. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles. Cancer. 2004;100:107-15.
40. Ivanovski M, Silvestri F, Pozzato G, et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood. 1998;91:2433-42.
41. Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S. The B cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin's lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood. 2001;98:3745-9.
42. Gisbert JP, Garcia-Buey L, Pajares JM, Moreno Otero R. Prevalence of hepatitis C virus infection in B cell non Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology. 2003;125:1723-32.